Výsledky vyhledávání

Akademický článek

Using real-world data to dynamically predict flares during tapering of biological DMARDs in rheumatoid arthritis: development, validation, and potential impact of prediction-aided decisions

Autor: Matthijs S. van der Leeuw, Marianne A. Messelink, Janneke Tekstra, Ojay Medina, Jaap M. van Laar, Saskia Haitjema, Floris Lafeber, Josien J. Veris-van Dieren, Marlies C. van der Goes, Alfons A. den Broeder, Paco M. J. Welsing

Publikováno v: Arthritis Research & Therapy, Vol 24, Iss 1, Pp 1-11 (2022)

Abstract Background Biological disease-modifying antirheumatic drugs (bDMARDs) are effective in the treatment of rheumatoid arthritis. However, as bDMARDs may also lead to adverse events and are expensive, tapering them is of great clinical interest.

Externí odkaz: https://doaj.org/article/b92d4cd330bb41329143ebcf30cce34d

Zobrazit plný text záznamu

Akademický článek

Time to minimal disease activity in relation to quality of life, productivity, and radiographic damage 1 year after diagnosis in psoriatic arthritis

Autor: Kim Wervers, Jolanda J. Luime, Ilja Tchetverikov, Andreas H. Gerards, Marc R. Kok, Cathelijne W. Y. Appels, Wiebo L. van der Graaff, Johannes H. L. M. van Groenendael, Lindy-Anne Korswagen, Josien J. Veris-van Dieren, Johanna M. W. Hazes, Marijn Vis, on behalf of Cicero

Publikováno v: Arthritis Research & Therapy, Vol 21, Iss 1, Pp 1-7 (2019)

Abstract Background In a cohort of patients with newly diagnosed psoriatic arthritis (PsA) who received usual care, we investigated the impact of time elapsed to minimal disease activity (MDA) on health-related quality of life (HRQoL), work productiv

Externí odkaz: https://doaj.org/article/1c005614541e429da7b5518378e1046b

Zobrazit plný text záznamu

Using real-world data to dynamically predict flares during tapering of biological DMARDs in rheumatoid arthritis: development, validation, and potential impact of prediction-aided decisions

Publikováno v: Arthritis Research & Therapy, 24, 1
Arthritis Research & Therapy, 24

Background Biological disease-modifying antirheumatic drugs (bDMARDs) are effective in the treatment of rheumatoid arthritis. However, as bDMARDs may also lead to adverse events and are expensive, tapering them is of great clinical interest. Tapering

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::19994d09ef291d51c2bc9588e17b3b46
https://pubmed.ncbi.nlm.nih.gov/35321739

Zobrazit plný text záznamu

Influence of Disease Manifestations on Health-related Quality of Life in Early Psoriatic Arthritis

Autor: K. Wervers, Cathelijne W. Y. Appels, Johanna M. W. Hazes, Lindy-Anne Korswagen, Marijn Vis, Josien J. Veris-van Dieren, Wiebo L. van der Graaff, Marc R. Kok, Johannes H L M van Groenendael, Andreas H. Gerards, Ilja Tchetverikov, Jolanda J. Luime

Publikováno v: Journal of Rheumatology, 45(11), 1526-1531. Journal of Rheumatology

Objective.Psoriatic arthritis (PsA) is a multifaceted disease. Affecting joints, skin, entheses, and dactylitis, its effect on health-related quality of life (HRQOL) could be substantial. We aim to assess HRQOL in patients newly diagnosed with PsA an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6db68cb59e147eed0da1879f219e125b
https://pure.eur.nl/en/publications/88ab431e-c0ee-4fa1-96a1-d131ee10c826

Zobrazit plný text záznamu

SAT0401 USE OF AND RESPONSE TO METHOTREXATE IN EARLY PSORIATIC ARTHRITIS: RESULTS FROM THE REAL WORLD COHORT, DEPAR STUDY

Autor: K. Wervers, Wiebo L. van der Graaff, Marijn Vis, Josien J. Veris-van Dieren, Marc R. Kok, Johanna M. W. Hazes, Hannah den Braanker, Cathelijne W. Y. Appels, Cicero, Lindy-Anne Korswagen, Andreas H. Gerards, Hans van Groenendael, Ilja Tchetverikov, Jolanda J. Luime

Publikováno v: Saturday, 15 June 2019.

Background: Methotrexate (MTX) is the preferred drug of most rheumatologists for treating psoriatic arthritis (PsA). Despite its widespread use in clinical practice, scientific evidence of methotrexate on the different manifestations of psoriatic dis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ae950a14d5ff5d785bcb1329b93ab7e0
https://doi.org/10.1136/annrheumdis-2019-eular.5371

Zobrazit plný text záznamu

Comparison of disease activity measures in early psoriatic arthritis in usual care

Autor: Marijn Vis, K. Wervers, Josien J. Veris-van Dieren, Johanna M. W. Hazes, for Cicero, Andreas H. Gerards, Jolanda J. Luime, Ilja Tchetverikov, Lindy-Anne Korswagen, Cathelijne W. Y. Appels, Johannes H L M van Groenendael, Wiebo L. van der Graaff, Marc R. Kok

Publikováno v: Rheumatology (Oxford, England)
Rheumatology, 58(12), 2251-2259. Oxford University Press

Objectives To compare responsiveness and longitudinal validity of Disease Activity Score 28 (DAS28), Disease Activity index for PSoriatic Arthritis (DAPSA), Composite Psoriatic Disease Activity Index (CPDAI), Psoriatic ArthritiS Disease Activity Scor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::946468559ec5e633d8cb5567b90fedf1
https://pubmed.ncbi.nlm.nih.gov/31211399

Zobrazit plný text záznamu

Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis

Autor: Marc R. Kok, Johannes H L M van Groenendael, Cathelijne W. Y. Appels, Ilja Tchetveriko, Wiebo L. van der Graaff, K. Wervers, Marijn Vis, Josien J. Veris-van Dieren, Andreas H. Gerards, Johanna M. W. Hazes, Jolanda J. Luime, Lindy-Anne Korswagen

Publikováno v: Arthritis Care & Research
Arthritis Care & Research, 70(12), 1764-1770. John Wiley & Sons Inc.

Objective Treat-to-target strategies have improved outcomes in rheumatic diseases. In psoriatic arthritis (PsA), the proposed targets are the multidimensional target minimal disease activity (MDA) and the articular target Disease Activity index for P

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01d2b6a542f6b5e7699ac31dc51f2d49
https://pubmed.ncbi.nlm.nih.gov/29609220

Zobrazit plný text záznamu

FRI0497 What choices do rheumatologist make in escalating dmard therapy in early psa?

Autor: M. Hazes, W vd Graaff, Jolanda J. Luime, J. Veris, C. Appels, Marijn Vis, K. Wervers, L-A Korswagen, Andreas H. Gerards, H. Van Groenendael, Marc R. Kok, Ilja Tchetverikov

Publikováno v: Poster Presentations.

Background Psoriatic arthritis (PsA) is a multifaceted disease. Objectives We aimed to evaluate change in medication over time guided by joints, skin, enthesis, low back pain and dactylitis in newly diagnosed PsA patients Methods Newly diagnosed PsA

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::82c914d0c2587ee8f326031d2d85c6de
https://doi.org/10.1136/annrheumdis-2017-eular.5922

Zobrazit plný text záznamu

AB0725 Using a reduced joint count in measuring disease activity in psoriatic arthritis, is it legit?

Autor: K. Wervers, Ilja Tchetverikov, C. Appels, Marijn Vis, Jolanda J. Luime, Andreas H. Gerards, M. Hazes, L-A Korswagen, H. van Groenendaal, Marc R. Kok, J. Veris

Publikováno v: Abstracts Accepted for Publication.

Background In Psoriatic arthritis (PsA) the pattern of joint involvement seems to be more heterogenic than Rheumatoid Arthritis (RA). Therefor the 66/68 joint count is frequently used in PsA scores. In this study we would like to investigate whether

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a3a890c7e5217b5625645c2fab01587e
https://doi.org/10.1136/annrheumdis-2017-eular.6851

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání